tstbio is a Taiwan based biomedical electronics span-off company established in 2018 by TST , Tai-Saw Technology Co., Ltd. Based on immunoassay and the core technology of Surface Acoustic Waves (SAW) of TST as well as of his long term strategic partner, JRC, Japan Radio Co., Ltd., tstbio has developed a simple and robust SAW biosensor platform, “iProtin” of POCT (point of care testing) for home and clinic applications. Besides, tstbio has carried different biomedical devices product lines to serve the growing health management demand for our community.
iProtin system enables multiple bio-markers’ tests in one common device.
iProtin Reader(CE & TFDA approval)
CRP assay cartridge kit (CE & TFDA approval)
Lp(a) assay cartridge kit (CE & TFDA approval)
COVID-19 S Protein Ab ( TFDA EUA approval is processing)
Besides inflammation detection, tstbio’s research and development team are developing other serious of protein markers for home care. For example, high-sensitivity CRP (hsCRP) and blood lipid protein ApoB as cardiovascular disease risk indicators; We are also developing viral detection for respiratory viral infections (RSV & hMPV).
Succeeding the core SAW technology of TST and of his strategic partner JRC, tstbio team has been executing research and development projects with some major central hospitals here in Taiwan. The iProtin system enables multiple tests and applications in one device. The iProtin system brings the benefits of portability, minimal training and maintenance allowing testing and monitoring to be undertaken anywhere by anyone. It is an easily handled and cost-effective device allowing rapid and reliable tests at the point-of-use. The quantitative results allow precise decisions for diagnosis and monitoring improving health and wellness. Only need one drop of finger-tip whole blood and within 3 minutes, the iProtin system can measure the biomarkers in human body.
tstbio welcomes partnerships to find new and additional applications for its technology to develop new products and discover new commercial opportunities. We have a strong intellectual property portfolio in support of our technology platform and full manufacturing capabilities to ISO13485.
